First Tracks Biotherapeutics Inc (TRAX)
NASDAQ:TRAX
Want to see TRAX full AI Analyst Report?
TRAX Stock Chart & Stats
18.16
-0.84(-4.42%)
―
--
Day’s Range― - ―
52-Week Range14.79 - 26.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding34,748,840
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$39.00Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
First Tracks Biotherapeutics Inc News
TRAX FAQ
What was First Tracks Biotherapeutics Inc’s price range in the past 12 months?
First Tracks Biotherapeutics Inc lowest stock price was 14.79 and its highest was 26.80 in the past 12 months.
What is First Tracks Biotherapeutics Inc’s market cap?
Currently, no data Available
When is First Tracks Biotherapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were First Tracks Biotherapeutics Inc’s earnings last quarter?
Currently, no data Available
Is First Tracks Biotherapeutics Inc overvalued?
According to Wall Street analysts First Tracks Biotherapeutics Inc’s price is currently Undervalued.
Does First Tracks Biotherapeutics Inc pay dividends?
First Tracks Biotherapeutics Inc does not currently pay dividends.
What is First Tracks Biotherapeutics Inc’s EPS estimate?
First Tracks Biotherapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does First Tracks Biotherapeutics Inc have?
First Tracks Biotherapeutics Inc has 34,748,840 shares outstanding.
What happened to First Tracks Biotherapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of First Tracks Biotherapeutics Inc?
Currently, no hedge funds are holding shares in TRAX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
TRAX Stock 12 Month Forecast
Average Price Target
$39.00